Renaud La Joie

Renaud La Joie publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Renaud La Joie sits on this spectrum.

Renaud La Joie D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Renaud La Joie sits on this spectrum.

Overview

Best Publications

• Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

  Alexandre Bejanin;Daniel R Schonhaut;Renaud La Joie;Joel H Kramer

  769
  Citations

• Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.

  Elisabeth H. Thijssen;Elisabeth H. Thijssen;Renaud La Joie;Amy Wolf;Amelia Strom

  738
  Citations

• Four distinct trajectories of tau deposition identified in Alzheimer’s disease

  Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  683
  Citations

• The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

  Rik Ossenkoppele;Yolande A. L. Pijnenburg;David C. Perry;Brendan I. Cohn-Sheehy

  573
  Citations

• Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET

  Renaud La Joie;Adrienne V. Visani;Suzanne L. Baker;Jesse A. Brown

  545
  Citations

• Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.

  Elisabeth H Thijssen;Renaud La Joie;Amelia Strom;Corrina Fonseca

  539
  Citations

• Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease

  Anne Maass;Susan Landau;Suzanne L Baker;Andy Horng

  480
  Citations

• Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders

  Rik Ossenkoppele;Rik Ossenkoppele;Gil D. Rabinovici;Ruben Smith;Hanna Cho

  468
  Citations

• Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation

  Sylvia Villeneuve;Gil D. Rabinovici;Gil D. Rabinovici;Gil D. Rabinovici;Brendan I. Cohn-Sheehy;Brendan I. Cohn-Sheehy;Brendan I. Cohn-Sheehy;Cindee Madison

  455
  Citations

• Why musical memory can be preserved in advanced Alzheimer’s disease

  Jörn Henrik Jacobsen;Jörn Henrik Jacobsen;Johannes Stelzer;Johannes Stelzer;Thomas Hans Fritz;Thomas Hans Fritz;Gael Chételat

  400
  Citations

• Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

  Renaud La Joie;Audrey Perrotin;Louisa Barré;Caroline Hommet;Caroline Hommet

  398
  Citations

• Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.

  Gaël Chételat;Renaud La Joie;Nicolas Villain;Audrey Perrotin

  394
  Citations

• Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease

  Robin de Flores;Renaud La Joie;Gaël Chételat

  382
  Citations

• Quantitative Comparison of 21 Protocols for Labeling Hippocampal Subfields and Parahippocampal Subregions in In Vivo MRI: Towards a Harmonized Segmentation Protocol

  Paul A. Yushkevich;Robert S C Amaral;Jean C. Augustinack;Andrew R. Bender

  354
  Citations

• Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders

  Eider M. Arenaza-Urquijo;Brigitte Landeau;Renaud La Joie;Katell Mevel

  337
  Citations

• Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia.

  Renaud La Joie;Audrey Perrotin;Vincent de La Sayette;Stéphanie Egret

  307
  Citations

• Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

  Renaud La Joie;Nagehan Ayakta;Nagehan Ayakta;William W. Seeley;Ewa Borys

  302
  Citations

• Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.

  Rik Ossenkoppele;Rik Ossenkoppele;Ruben Smith;Niklas Mattsson-Carlgren;Colin Groot

  290
  Citations

• Longitudinal tau accumulation and atrophy in aging and alzheimer disease.

  Theresa M. Harrison;Renaud La Joie;Anne Maass;Anne Maass;Suzanne L. Baker

  262
  Citations

• Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease

  Rik Ossenkoppele;Brendan I. Cohn-Sheehy;Renaud La Joie;Jacob W. Vogel

  249
  Citations

• Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer’s disease

  Fanny M. Elahi;Kaitlin B. Casaletto;Renaud La Joie;Samantha M. Walters

  242
  Citations